Vanguard Group Inc. Has $528.27 Million Position in Ryan Specialty Holdings Inc. $RYAN

05 May 2026, 08:25 by Jessica Moore · The Cerbat Gem

Vanguard Group Inc. lowered its position in Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 0.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,231,737 shares of the company’s stock after selling 46,887 shares during the period. Vanguard Group Inc.’s holdings in Ryan Specialty were worth $528,265,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Montrusco Bolton Investments Inc. grew its holdings in Ryan Specialty by 9.3% during the fourth quarter. Montrusco Bolton Investments Inc. now owns 4,343,116 shares of the company’s stock valued at $218,010,000 after purchasing an additional 368,247 shares during the last quarter. Torray Investment Partners LLC grew its holdings in Ryan Specialty by 30.6% during the fourth quarter. Torray Investment Partners LLC now owns 60,384 shares of the company’s stock valued at $3,118,000 after purchasing an additional 14,156 shares during the last quarter. HB Wealth Management LLC grew its holdings in Ryan Specialty by 0.5% during the fourth quarter. HB Wealth Management LLC now owns 53,884 shares of the company’s stock valued at $2,782,000 after purchasing an additional 270 shares during the last quarter. M&T Bank Corp grew its holdings in Ryan Specialty by 94.5% during the fourth quarter. M&T Bank Corp now owns 97,680 shares of the company’s stock valued at $5,043,000 after purchasing an additional 47,458 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH boosted its position in shares of Ryan Specialty by 18.2% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 769,333 shares of the company’s stock valued at $40,312,000 after acquiring an additional 118,537 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Stock Down 3.9%

Shares of NYSE RYAN opened at $29.63 on Tuesday. The stock has a market cap of $7.83 billion, a PE ratio of 38.47, a PEG ratio of 0.86 and a beta of 0.68. The business has a fifty day moving average of $36.08 and a two-hundred day moving average of $46.33. Ryan Specialty Holdings Inc. has a 52-week low of $29.50 and a 52-week high of $72.50. The company has a debt-to-equity ratio of 2.90, a quick ratio of 0.98 and a current ratio of 1.02.

Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.04. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The company had revenue of $795.23 million during the quarter, compared to analyst estimates of $781.44 million. During the same period last year, the company posted $0.39 earnings per share. The firm’s quarterly revenue was up 15.2% compared to the same quarter last year. As a group, equities research analysts expect that Ryan Specialty Holdings Inc. will post 2.18 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th will be paid a $0.13 dividend. The ex-dividend date is Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.8%. Ryan Specialty’s dividend payout ratio (DPR) is 67.53%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on RYAN shares. Royal Bank Of Canada started coverage on Ryan Specialty in a research report on Tuesday, March 17th. They issued an “outperform” rating and a $45.00 price objective for the company. Cantor Fitzgerald reduced their price objective on Ryan Specialty from $45.00 to $40.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Citigroup reduced their price objective on Ryan Specialty from $55.00 to $50.00 and set a “buy” rating for the company in a research report on Monday. The Goldman Sachs Group reissued a “buy” rating and issued a $42.00 price objective on shares of Ryan Specialty in a research report on Friday. Finally, Morgan Stanley reduced their price objective on Ryan Specialty from $55.00 to $50.00 and set an “overweight” rating for the company in a research report on Monday, April 6th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $48.12.

Get Our Latest Research Report on RYAN

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the stock in a transaction dated Monday, February 23rd. The stock was bought at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the completion of the purchase, the director owned 428,295 shares in the company, valued at $17,114,668.20. This represents a 6.33% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 52.03% of the company’s stock.

About Ryan Specialty

(Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.